|
Multi-vessel disease, n (%)
|
517 (59.2)
|
41 (63.1)
|
0.601
|
363 (59.6)
|
194 (59.1)
|
0.889
|
|
Bifurcation lesion, n (%)
|
407 (32.8)
|
35 (38.5)
|
0.300
|
301 (33.8)
|
141 (32.3)
|
0.578
|
|
Thrombus-containing lesions, n (%)
|
113 (9.3)
|
5 (5.7)
|
0.336
|
77 (8.9)
|
41 (9.5)
|
0.683
|
|
IIb/IIIa Inhibitor, n (%)
|
122 (10.8)
|
7 (8.6)
|
0.709
|
96 (12.0)
|
33 (8.2)
|
0.048
|
|
DES used, n (%)
|
1240 (100)
|
91 (100)
|
NS
|
891 (100)
|
437 (100)
|
NS
|
|
Total implanted stent
|
2.78 ± 1.72
|
2.58 ± 1.61
|
0.287
|
2.81 ± 1.76
|
2.69 ± 1.62
|
0.235
|
|
Mean stent diameter, mm
|
3.08 ± 0.38
|
3.03 ± 0.34
|
0.313
|
3.08 ± 0.38
|
3.05 ± 0.39
|
0.155
|
|
Total stent length, mm
|
72.14 ± 48.69
|
65.06 ± 42.73
|
0.187
|
72.61 ± 49.14
|
69.77 ± 46.65
|
0.332
|
|
Complete revascularization, n (%)
|
823 (67.9)
|
59 (67.0)
|
0.906
|
598 (68.8)
|
281 (65.7)
|
0.256
|
|
Final TIMI grade 3, n (%)
|
1199 (98.2)
|
88 (98.9)
|
NS
|
860 (98.3)
|
424 (98.1)
|
0.827
|
|
Heparin volume, units
|
7915.11 ± 2027.05
|
8085.00 ± 1945.01
|
0.503
|
7892.79 ± 2029.11
|
7999.97 ± 2012.82
|
0.421
|
